Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;25(6):1195-1208.
doi: 10.1002/ejp.1742. Epub 2021 Feb 28.

Is opioid therapy for chronic non-cancer pain associated with a greater risk of all-cause mortality compared to non-opioid analgesics? A systematic review of propensity score matched observational studies

Thomas Tölle  1 , Mary-Ann Fitzcharles  2   3 , Winfried Häuser  4   5
Affiliations

Is opioid therapy for chronic non-cancer pain associated with a greater risk of all-cause mortality compared to non-opioid analgesics? A systematic review of propensity score matched observational studies

Thomas Tölle et al. Eur J Pain. 2021 Jul.

Abstract

Background: The many risks associated with opioid therapy for chronic non-cancer pain (CNCP) have led to questions about use. This is particularly relevant for risk of increased mortality. However, underlying medical conditions of those using opioids may influence mortality findings due to confounding by indication. Similarly, non-opioid analgesics are also associated with an increased risk of mortality, too.

Methods: We have conducted a systematic review of propensity score matched observational studies comparing mortality associated with opioid use compared to non-opioid analgesics. Clinicaltrials.gov, Google Scholar, MEDLINE and Scopus were searched from inception to July 2020. Propensity score matched observational studies comparing opioids to non-opioid analgesics in real-world settings were analysed. Primary outcome was pooled adjusted hazard ratio (aHR) of all-cause death. Effects were summarized by a random effects model.

Results: Four studies with seven study arms and 120,186 patients were analysed. Pooled aHR for all-cause death was 1.69 (95% confidence interval [CI] 1.47, 1.95). When mortality risk was confined to out-of-hospital deaths, the pooled aHR was 2.12 (95% CI 1.46, 3.09). The most frequent cause of death was cardiovascular death. Before matching, patients with opioids were older and had more somatic diseases than patients with non-opioids. Despite extensive propensity score matchings and sensitivity analyses, all studies could not fully exclude confounding by indication.

Conclusions: Possibly, opioids are associated with an increased all-cause mortality risk compared to non-opioid analgesics. When considering treatment options for patients with CNCP, the possible risk of increased all-cause mortality with opioids should be discussed.

Significance: An increased all-cause mortality associated with opioid use compared to non-opioid analgesics for CNCP was identified by a systematic review of four propensity score matched cohort studies in real-world settings. The number needed to harm for an additional excess death per 10,000 person-years was 116. Despite extensive propensity score matchings and sensitivity analyses, all studies could not fully exclude confounding by indication. The potential risk of increased all-cause mortality with opioids should be discussed with patients when considering opioid treatment.

PubMed Disclaimer

References

REFERENCES
    1. Barnett, M. L. (2020). Opioid prescribing in the midst of crisis - Myths and realities. New England Journal of Medicine, 382, 1086-1088. https://doi.org/10.1056/NEJMp1914257
    1. Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-1101. https://doi.org/10.2307/2533446
    1. Bialas, P., Maier, C., Klose, P., & Häuser, W. (2020). Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: Systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks. European Journal of Pain, 24, 265-278. https://doi.org/10.1002/ejp.1496
    1. Borate, U. M., Mineishi, S., & Costa, L. J. (2015). Nonbiological factors affecting survival in younger patients with acute myeloid leukemia. Cancer, 121, 3877-3884. https://doi.org/10.1002/cncr.29436
    1. Bosco, J. L. F., Silliman, R. A., Thwin, S. S., Geiger, A. M., Buist, D. S. M., Prout, M. N., Yood, M. U., Haque, R., Wei, F., & Lash, T. L. (2010). A most stubborn bias: No adjustment method fully resolves confounding by indication in observational studies. Journal of Clinical Epidemiology, 63, 64-74. https://doi.org/10.1016/j.jclinepi.2009.03.001
Web references
    1. Viswanathan, M., Ansari, M. T., Berkman, N. D., Chang, S., Hartling, L., & McPheeters, L. M. (2012). Assessing the risk of bias of individual studies in systematic reviews of health care interventions. Agency for Healthcare Research and Quality Methods Guide for Comparative Effectiveness Reviews. March 2012. AHRQ Publication No. 12-EHC047-EF. Retrieved from https://effectivehealthcare.ahrq.gov/
    1. Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2012). The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Retrieved from http://wwwohrica/programs/clinical_epidemiology/oxfordasp

Publication types

Substances

LinkOut - more resources